ATRX and pancreatic insulinoma: In recently published work, mutations in Men1, Daxx, and Atrx were shown to be less common in human insulinomas than in human nonfunctioning tumors, suggesting that subtypes of PanNETs are influenced by the presence of these driver mutations37.